CeMMinars
03.12.2012
Anne Corcoran
Nuclear Dynamics Programme Babraham Institute, Cambridge, United Kingdom
“Non-coding RNA transcription and nuclear organisation play key roles in immunoglobulin Recombination”
29.10.2012
Michael White
University of Texas, UT Southwestern Medical Center, United States
“Oncogenome - selective vulnerabilities in lung adenocarcinoma”
15.10.2012
Christoph Plass
Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center in the Helmholtz Association, Germany
“Global epigenetic alterations in chronic lymphocytic leukemia”
08.10.2012
Paul Flicek
EMBL Outstation - Hinxton, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom
“Comparative regulatory genomics provides insight into the evolution of transcriptional regulation”
01.10.2012
Matthias Mann
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Germany
“Comprehensive proteome analysis and some of its applications”
23.07.2012
Andrew MCKenzie
MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
“Type-2 innate lymphoid cells in protective immunity and asthma“
25.06.2012
Michael Hemann
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), United States
“Using mouse models to identify new cancer drug targets”
18.06.2012
Garret A. FitzGerald
Department of Pharmacology, Institute for Translational Medicine & Therapeutics (ITMAT), Perelman School of Medicine, University of Pennsylvania, United States
“Peripheral Clocks in Cardiometabolic Function”
04.06.2012
Maria Sibilia
Institute for Cancer Research, Dept. of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Austria
“Defining the functions of EGFR in Cancer and beyond”
21.05.2012
Amos Bairoch
Director of Structural Biology and Bioinformatics Department, Swiss Institute of Bioinformatics, University of Geneva, Switzerland
“The CALIPHO group: neXtProt, a new knowledge platform on human proteins and on-going work toward the characterization of some human proteins”
14.05.2012
Michael J. Eck
Department of Cancer Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States
“TKinase Targets in Lung Cancer: Structure, mechanism and inhibition of EGFR and TBK1”
07.05.2012
Claus Nerlov
MRC Centre for Regenerative Medicine SCRM Building, The University of Edinburgh, Scotland
“Identification of novel pathways & mechanisms of hematopoitic lineage specification”
23.04.2012
Philippe Sansonetti
INSERM U786 “Unité de Pathogénie Microbienne Moléculaire”, Institut Pasteur, Paris, France
“Unité de Pathogénie Microbienne Moléculaire”
16.04.2012
Forest White
Department of Biological Engineering, Massachusetts Institute of Technology (MIT) and Koch Institute for Integrative Cancer Research, USA
“Using Quantitative Proteomics to Connect Genotype to Phenotype”
02.04.2012
Julie Magarian Blander
Immunology Institute, Mount Sinai Medical Center, New York, United States
“Vita-PAMPs: Signatures of Microbial Viability”
26.03.2012
Jean-Laurent Casanova
St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, United States
“Toward a genetic theory of infectious diseases”
12.03.2012
Laurence Calzone & Emmanuel Barillot
Computational Systems Biology of Cancer, Institute Curie, Paris, France
“A Systems Biology Approach for modeling signalling network involved in Cancer”
05.03.2012
Kai Johnson
Institute of Chemical Sciences & Engineering, École Polytechnique Fédérale de Lausanne, Switzerland
“Spying on drugs and metabolites in living cells”
27.02.2012
Axel Behrens
CR-UK London Research Institute, United Kingdom
“Stress and DNA damage signalling in stem cells and cancer”
20.02.2012
Magnus Nordborg
Gregor Mendel Institute of Molecular Plant Biology (GMI), Vienna, Austria
“Investigating the genotype-phenotype map using Arabidopsis”
13.02.2012
Bodo Grimbacher
Research group “Experimental Immunodeficiency“, Centre of Chronic Immunodeficiency, Freiburg, Germany
“A novel monogenetic defect causing autoimmunity and hypogammaglobulinemia”
06.02.2012
Kristian Helin
Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Denmark
“Functional Roles of TET proteins and Hydroxymethylation in Stem Cells and Cancer”
30.01.2012
Meinrad Busslinger
The Research Institute of Molecular Pathology (IMP), Vienna, Austria
“Lineage commitment and plasticity of B lymphocytes”